Warts are a neoplasm on the skin caused by the human papilloma virus. It is more common in children and young people, the incubation period is 1 to 3 months, and it can spread by self-inoculation. The virus exists in the spinous cells, which can promote cell proliferation and cause wart-like damage.
This report contains market size and forecasts of Warts Therapeutics in Global, including the following market information:
Global Warts Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Warts Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Common Warts Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Warts Therapeutics include GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd, Phio Pharmaceuticals Corporation, Pfizer, Inc, Verrica Pharmaceuticals, Bausch Health Companies, Inc, Prestige Consumer Healthcare Inc, Taro Pharmaceutical Industries Ltd and Cipla Ltd, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Warts Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Warts Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Warts Therapeutics Market Segment Percentages, by Type, 2021 (%)
Common Warts
Plantar Warts
Flat Warts
Others
Global Warts Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Warts Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospital
Homecare
Specialty Clinics
Dermatologist
Others
Global Warts Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Warts Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Warts Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Warts Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline plc
Teva Pharmaceutical Industries Ltd
Phio Pharmaceuticals Corporation
Pfizer, Inc
Verrica Pharmaceuticals
Bausch Health Companies, Inc
Prestige Consumer Healthcare Inc
Taro Pharmaceutical Industries Ltd
Cipla Ltd
Novan Inc
AIM ImmunoTech, Inc